N-methyl-D-aspartate (NMDA)-induced seizures in developing rats
Jazyk angličtina Země Nizozemsko Médium print
Typ dokumentu časopisecké články
PubMed
1572063
DOI
10.1016/0165-3806(92)90178-y
PII: 0165-3806(92)90178-Y
Knihovny.cz E-zdroje
- MeSH
- elektroencefalografie účinky léků MeSH
- injekce intraperitoneální MeSH
- krysa rodu Rattus MeSH
- N-methylaspartát aplikace a dávkování toxicita MeSH
- pohybová aktivita účinky léků MeSH
- stárnutí fyziologie MeSH
- záchvaty chemicky indukované patofyziologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- N-methylaspartát MeSH
Intraperitoneal administration of N-methyl-D-aspartate (NMDA) elicited epileptic motor seizures in developing rats aged from 7 to 25 days as well as in young adults. The very first sign of NMDA action is locomotor hyperactivity which is followed by clonic and tonic seizures. In rat pups during the first 3 postnatal weeks flexion seizures (emprosthotonus) appeared as the first pattern of motor seizures; later they were replaced by generalized tonic clonic seizures. Only regular tonic-clonic seizures were observed in 25-day-old and adult rats. The youngest animals are the most sensitive to NMDA. CD50 for tonic-colonic seizures is 6.7 mg/kg in 7-day-old rat pups and it increases up to 86.6 mg/kg in 25-day-old animals. Similar changes could also be demonstrated for LD50, a lethal outcome being very frequent. EEG recordings demonstrated mainly suppressed activity, thus exhibiting a lack of correlation with motor phenomena.
Citace poskytuje Crossref.org
Epilepsy Research in the Institute of Physiology of the Czech Academy of Sciences in Prague
Convulsant action of a benzodiazepine receptor agonist/inverse agonist Ro 19-4603 in developing rats